Wave Life Sciences WVE
NASDAQ WVE
$3.78 -0.10 (-2.58%)
At close: Oct 2, 2026 · 4:00 PM EDT

Wave Life Sciences (WVE) Selling, General & Administrative (2014 - 2026)

Updated

Wave Life Sciences' Selling, General & Administrative came in at $24.78 million for Q2 2026, up 37.8% from $17.99 million a year earlier and up 12.1% from the prior quarter.

Analysis

Wave Life Sciences (WVE) Selling, General & Administrative (2014 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Wave Life Sciences reported Selling, General & Administrative of $85.87 million, up 27.2% year-over-year; for FY2025, it was $75.33 million, up 27.6% from FY2024.

  • Selling, General & Administrative has increased in each of the last five years, with a five-year compound annual growth rate of 12.1% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $59.02 million in FY2024 (+15.1%), $51.29 million in FY2023 (+1.5%), $50.51 million in FY2022 (+9.6%) and $46.11 million in FY2021 (+8.5%).
  • The Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to Q3 2014.
  • Year-over-year, Selling, General & Administrative has increased for ten consecutive quarters, with growth averaging 25.2% over the last eight quarters.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q2 2026 (growth of 37.8%), and the weakest in Q3 2022 (a decline of 10.3%).
  • Business Quant data shows WVE's Selling, General & Administrative at $22.1 million (Q1 2026), $20.9 million (Q4 2025) and $18.09 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Wave Life Sciences 730.59 Mn -980.30 Mn - 24.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.78 Mn
Mar 31, 2026 22.10 Mn
Dec 31, 2025 20.90 Mn
Sep 30, 2025 18.09 Mn
Jun 30, 2025 17.99 Mn
Mar 31, 2025 18.36 Mn
Dec 31, 2024 16.14 Mn
Sep 30, 2024 15.04 Mn
Jun 30, 2024 14.30 Mn
Mar 31, 2024 13.55 Mn
Dec 31, 2023 13.66 Mn
Sep 30, 2023 13.13 Mn
Jun 30, 2023 12.27 Mn
Mar 31, 2023 12.24 Mn
Dec 31, 2022 13.72 Mn
Sep 30, 2022 11.61 Mn
Jun 30, 2022 12.81 Mn
Mar 31, 2022 12.37 Mn
Dec 31, 2021 12.11 Mn
Sep 30, 2021 12.94 Mn
API Access

Wave Life Sciences Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=WVE&period=max&api_key=YOUR_API_KEY